ITGB4
Integrin beta-4
Also known as: CD104, ITB4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P16144
- Gene
- ITGB4
- Ensembl
- ENSG00000132470
- Chromosome
- 17
- Canonical length
- 1822 aa
- Protein class
- Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Plasma membrane,Cell Junctions
OverviewNCBI Gene
Integrins are heterodimers comprised of alpha and beta subunits, that are noncovalently associated transmembrane glycoprotein receptors. Different combinations of alpha and beta polypeptides form complexes that vary in their ligand-binding specificities. Integrins mediate cell-matrix or cell-cell adhesion, and transduced signals that regulate gene expression and cell growth. This gene encodes the integrin beta 4 subunit, a receptor for the laminins. This subunit tends to associate with alpha 6 subunit and is likely to play a pivotal role in the biology of invasive carcinoma. Mutations in this gene are associated with epidermolysis bullosa with pyloric atresia. Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1822 residues, UniProt reviewed canonical sequence.
>P16144|ITGB4
1 MAGPRPSPWA RLLLAALISV SLSGTLANRC KKAPVKSCTE CVRVDKDCAY CTDEMFRDRR
61 CNTQAELLAA GCQRESIVVM ESSFQITEET QIDTTLRRSQ MSPQGLRVRL RPGEERHFEL
121 EVFEPLESPV DLYILMDFSN SMSDDLDNLK KMGQNLARVL SQLTSDYTIG FGKFVDKVSV
181 PQTDMRPEKL KEPWPNSDPP FSFKNVISLT EDVDEFRNKL QGERISGNLD APEGGFDAIL
241 QTAVCTRDIG WRPDSTHLLV FSTESAFHYE ADGANVLAGI MSRNDERCHL DTTGTYTQYR
301 TQDYPSVPTL VRLLAKHNII PIFAVTNYSY SYYEKLHTYF PVSSLGVLQE DSSNIVELLE
361 EAFNRIRSNL DIRALDSPRG LRTEVTSKMF QKTRTGSFHI RRGEVGIYQV QLRALEHVDG
421 THVCQLPEDQ KGNIHLKPSF SDGLKMDAGI ICDVCTCELQ KEVRSARCSF NGDFVCGQCV
481 CSEGWSGQTC NCSTGSLSDI QPCLREGEDK PCSGRGECQC GHCVCYGEGR YEGQFCEYDN
541 FQCPRTSGFL CNDRGRCSMG QCVCEPGWTG PSCDCPLSNA TCIDSNGGIC NGRGHCECGR
601 CHCHQQSLYT DTICEINYSA IHPGLCEDLR SCVQCQAWGT GEKKGRTCEE CNFKVKMVDE
661 LKRAEEVVVR CSFRDEDDDC TYSYTMEGDG APGPNSTVLV HKKKDCPPGS FWWLIPLLLL
721 LLPLLALLLL LCWKYCACCK ACLALLPCCN RGHMVGFKED HYMLRENLMA SDHLDTPMLR
781 SGNLKGRDVV RWKVTNNMQR PGFATHAASI NPTELVPYGL SLRLARLCTE NLLKPDTREC
841 AQLRQEVEEN LNEVYRQISG VHKLQQTKFR QQPNAGKKQD HTIVDTVLMA PRSAKPALLK
901 LTEKQVEQRA FHDLKVAPGY YTLTADQDAR GMVEFQEGVE LVDVRVPLFI RPEDDDEKQL
961 LVEAIDVPAG TATLGRRLVN ITIIKEQARD VVSFEQPEFS VSRGDQVARI PVIRRVLDGG
1021 KSQVSYRTQD GTAQGNRDYI PVEGELLFQP GEAWKELQVK LLELQEVDSL LRGRQVRRFH
1081 VQLSNPKFGA HLGQPHSTTI IIRDPDELDR SFTSQMLSSQ PPPHGDLGAP QNPNAKAAGS
1141 RKIHFNWLPP SGKPMGYRVK YWIQGDSESE AHLLDSKVPS VELTNLYPYC DYEMKVCAYG
1201 AQGEGPYSSL VSCRTHQEVP SEPGRLAFNV VSSTVTQLSW AEPAETNGEI TAYEVCYGLV
1261 NDDNRPIGPM KKVLVDNPKN RMLLIENLRE SQPYRYTVKA RNGAGWGPER EAIINLATQP
1321 KRPMSIPIIP DIPIVDAQSG EDYDSFLMYS DDVLRSPSGS QRPSVSDDTG CGWKFEPLLG
1381 EELDLRRVTW RLPPELIPRL SASSGRSSDA EAPHGPPDDG GAGGKGGSLP RSATPGPPGE
1441 HLVNGRMDFA FPGSTNSLHR MTTTSAAAYG THLSPHVPHR VLSTSSTLTR DYNSLTRSEH
1501 SHSTTLPRDY STLTSVSSHD SRLTAGVPDT PTRLVFSALG PTSLRVSWQE PRCERPLQGY
1561 SVEYQLLNGG ELHRLNIPNP AQTSVVVEDL LPNHSYVFRV RAQSQEGWGR EREGVITIES
1621 QVHPQSPLCP LPGSAFTLST PSAPGPLVFT ALSPDSLQLS WERPRRPNGD IVGYLVTCEM
1681 AQGGGPATAF RVDGDSPESR LTVPGLSENV PYKFKVQART TEGFGPEREG IITIESQDGG
1741 PFPQLGSRAG LFQHPLQSEY SSITTTHTSA TEPFLVDGLT LGAQHLEAGG SLTRHVTQEF
1801 VSRTLTTSGT LSTHMDQQFF QTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ITGB4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 199 nTPM
Expression across tissuesHPA
Tissue
- skin: 199 nTPM
- salivary gland: 198 nTPM
- esophagus: 100 nTPM
- vagina: 97 nTPM
- choroid plexus: 97 nTPM
- colon: 86 nTPM
Single-cell type
- salivary basal cells: 319 nCPM
- schwann cells: 310 nCPM
- respiratory basal cells: 234 nCPM
- foveolar cells: 218 nCPM
- salivary myoepithelial cells: 212 nCPM
- basal prostatic cells: 162 nCPM
Immune cell
- plasmacytoid DC: 4.6 nTPM
- naive B-cell: 2 nTPM
- MAIT T-cell: 1.1 nTPM
- T-reg: 0.8 nTPM
- memory B-cell: 0.7 nTPM
- neutrophil: 0.7 nTPM
Brain region
- midbrain: 124 nTPM
- medulla oblongata: 124 nTPM
- spinal cord: 118 nTPM
- white matter: 108 nTPM
- hypothalamus: 85 nTPM
- basal ganglia: 85 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ITGB4.
Disease | AllUniProt
Conditions ITGB4 is implicated in, by any mechanism.
- Epidermolysis bullosa, junctional 5A, intermediate (JEB5A) MIM:619816
- Epidermolysis bullosa, junctional 5B, with pyloric atresia (JEB5B) MIM:226730
Disease | GeneticClinVar
158 pathogenic / likely-pathogenic of 1,953 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Junctional epidermolysis bullosa with pyloric atresia
- Epidermolysis bullosa, junctional 5A, intermediate
- ITGB4-related disorder
- Epidermolysis bullosa simplex 1C, localized
- Junctional epidermolysis bullosa
ReferencesPubMed · IEDB
Publications for ITGB4 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Integrin β4 is a major target antigen in pure ocular mucous membrane pemphigoid.
2016 · Eur J Dermatol · RCR 1.9 · 32 citations - A Case of Anti-BP180-type Mucous Membrane Pemphigoid with IgG and IgA Autoantibodies Showing Distinct Reactivities.
2022 · Acta Dermatovenerol Croat
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.65
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.37
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- autophagy
- cell adhesion
- cell adhesion mediated by integrin
- cell migration
- cell motility
- cell-cell adhesion
- cell-matrix adhesion
- filopodium assembly
- hemidesmosome assembly
- integrin-mediated signaling pathway
- mesodermal cell differentiation
- nail development
- peripheral nervous system myelin formation
- response to wounding
- skin morphogenesis
- trophoblast cell migration
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- EGF-like domain
- Integrin beta subunit, VWA domain
- Na-Ca exchanger/integrin-beta4
- Fibronectin type III
- Integrin beta subunit, tail
- Immunoglobulin-like fold
- Integrin beta subunit
- PSI domain
- Integrin beta N-terminal
- Fibronectin type III superfamily
- Integrin beta tail domain superfamily
- von Willebrand factor A-like domain superfamily
- CalX-like domain superfamily
- Integrin beta, epidermal growth factor-like domain 1
- Integrins beta, I-EGF domain, conserved site
- Fibronectin type III domain
- Integrin beta chain VWA domain
- Calx-beta domain
- Integrin beta tail domain
- Integrin plexin domain
- Integrin beta epidermal growth factor like domain 1
- Teneurin-like EGF domain
- Integrin beta-4 subunit
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ITGB4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ITGB4 as an antibody target. Whether an autoantibody or antibody against ITGB4 could matter depends on whether native ITGB4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ITGB4 is annotated at the cell surface, where native ITGB4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ITGB4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...